Table 2 Nodular sclerosis (N*=184)
N | ++ | + | − | %+ | |
---|---|---|---|---|---|
CD20 | 171 | — | 22 | 149 | 13 |
CD79a | 141 | — | 19 | 122 | 13 |
PAX.5 | 153 | 40 | 113 | 0 | 100 |
MUM.1 | 162 | 74 | 83 | 5 | 97 |
OCT.1 | 182 | 14 | 83 | 85 | 53 |
OCT.2 | 182 | — | 111 | 71 | 61 |
BOB.1 | 173 | 27 | 40 | 106 | 39 |
N | ++ | + | − | %+ | |
---|---|---|---|---|---|
CD20 | 171 | — | 22 | 149 | 13 |
CD79a | 141 | — | 19 | 122 | 13 |
PAX.5 | 153 | 40 | 113 | 0 | 100 |
MUM.1 | 162 | 74 | 83 | 5 | 97 |
OCT.1 | 182 | 14 | 83 | 85 | 53 |
OCT.2 | 182 | — | 111 | 71 | 61 |
BOB.1 | 173 | 27 | 40 | 106 | 39 |